The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Dual immune checkpoint blockade in advanced well-differentiated neuroendocrine tumors, a phase II clinical trial.
 
Susan Combs Scott
No Relationships to Disclose
 
Ana De Jesus-Acosta
Consulting or Advisory Role - Merck
Research Funding - AstraZeneca (Inst); Merck (Inst)
 
Chen Hu
Consulting or Advisory Role - Merck Sharp & Dohme
 
Benjamin Philip Levy
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo/Astra Zeneca; Genentech/Roche; Guardant Health; Lilly; Merck; Novartis; Pfizer; Takeda
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Loxo (Inst); Merck (Inst); Turning Point Therapeutics (Inst)
 
Valsamo Anagnostou
Research Funding - Bristol-Myers Squibb; Personal Genome Diagnostics
 
Julie R. Brahmer
Honoraria - Roche/Genentech
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; Genentech; GlaxoSmithKline; Lilly; Merck; Regeneron; Sanofi
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); RAPT Therapeutics (Inst); Revolution (Inst); Spectrum Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Roche/Genentech
Other Relationship - Bristol-Myers Squibb; Janssen Oncology; merck
 
Peter Bela Illei
Stock and Other Ownership Interests - Bristol-Myers Squibb; Xoma
Consulting or Advisory Role - AstraZeneca; Veran Medical Technologies
Research Funding - Bristol-Myers Squibb (Inst); Erbe USA (Inst)
 
Elizabeth M. Jaffee
Stock and Other Ownership Interests - ABMETA Therapeutics
Consulting or Advisory Role - Achilles Therapeutics; Adaptive Biotechnologies; Avidea Technologies; CStone Pharmaceuticals; Dragonfly Therapeutics; Genocea Biosciences; Incyte; Medically Home
Research Funding - Aduro Biotech; Amgen; Avidea Technologies; Bristol-Myers Squibb; Corvus Pharmaceuticals; Roche
Patents, Royalties, Other Intellectual Property - I developed GVAX which is being tested in the clinics. It was licensed to Adoro Biotech. IF it becomes commercial I will have the potential to receive royalties. Also, I have received milestone payments yearly.
Travel, Accommodations, Expenses - Bristol-Myers Squibb; CStone Pharmaceuticals; Genocea Biosciences; Medically Home; MedImmune
Other Relationship - Dragonfly Therapeutics
 
Kristen Marrone
Honoraria - AstraZeneca
Consulting or Advisory Role - Amgen; AstraZeneca; Compugen
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst)
 
Patrick M. Forde
Consulting or Advisory Role - Abbvie; Amgen; Amgen; AstraZeneca/MedImmune; Bristol-Myers Squibb; Daiichi Sankyo/UCB Japan; Janssen
Research Funding - AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Corvus Pharmaceuticals; Kyowa Hakko Kirin (Inst); Novartis (Inst)
 
Christine L. Hann
Consulting or Advisory Role - Amgen; Ascentage Pharma; AstraZeneca
Research Funding - Abbvie (Inst); Amgen (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst)
Travel, Accommodations, Expenses - AstraZeneca